Amalgamated Bank’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$301K Sell
10,651
-642
-6% -$15K ﹤0.01% 1497
2026
Q1
$215K Sell
11,293
-53
-0.5% -$1.17K ﹤0.01% 1541
2025
Q4
$274K Buy
11,346
+448
+4% +$11.7K ﹤0.01% 1493
2025
Q3
$278K Buy
10,898
+366
+3% +$8.68K ﹤0.01% 1488
2025
Q2
$227K Buy
10,532
+202
+2% +$4.55K ﹤0.01% 1523
2025
Q1
$236K Sell
10,330
-160
-2% -$4.21K ﹤0.01% 1490
2024
Q4
$272K Sell
10,490
-96
-0.9% -$2.39K ﹤0.01% 1493
2024
Q3
$265K Sell
10,586
-202
-2% -$4.77K ﹤0.01% 1507
2024
Q2
$231K Sell
10,788
-324
-3% -$6.29K ﹤0.01% 1542
2024
Q1
$206K Sell
11,112
-3,611
-25% -$63.1K ﹤0.01% 1597
2023
Q4
$239K Sell
14,723
-945
-6% -$12.1K ﹤0.01% 1739
2023
Q3
$216K Hold
15,668
﹤0.01% 1762
2023
Q2
$346K Buy
15,668
+1,321
+9% +$27.8K ﹤0.01% 1607
2023
Q1
$312K Sell
14,347
-1,077
-7% -$24.2K ﹤0.01% 1627
2022
Q4
$281K Hold
15,424
﹤0.01% 1721
2022
Q3
$351K Buy
15,424
+1,214
+9% +$26K ﹤0.01% 1595
2022
Q2
$196K Buy
14,210
+2,994
+27% +$43.9K ﹤0.01% 1886
2022
Q1
$255K Sell
11,216
-729
-6% -$19.2K ﹤0.01% 1837
2021
Q4
$445K Sell
11,945
-2,599
-18% -$112K ﹤0.01% 1633
2021
Q3
$616K Buy
14,544
+9,935
+216% +$478K 0.01% 1475
2021
Q2
$205K Buy
+4,609
New +$162K ﹤0.01% 2020

Other funds holding BLFS

Amalgamated Bank's BLFS Position: Q2 2026 in Review

Amalgamated Bank reduced its BioLife Solutions (BLFS) stake by 5.7% in Q2 2026, selling an estimated $15K and leaving 10,651 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #1497.

Amalgamated Bank first reported a position in BLFS in Q2 2021 and has held it in 21 quarters since. The position peaked at $616K in Q3 2021. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Amalgamated Bank held 10,651 shares of BioLife Solutions worth $301K as of Q2 2026.
  • Amalgamated Bank sold 642 BioLife Solutions shares in Q2 2026, an estimated $15K.
  • BioLife Solutions made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1497 holding.
  • Amalgamated Bank first reported a position in BioLife Solutions in Q2 2021 and has held it in 21 quarters since.
  • Amalgamated Bank's BioLife Solutions position peaked at $616K in Q3 2021.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.